Quoin Pharmaceuticals Ltd. - 8-K Filing

Quoin Pharmaceuticals receives FDA Rare Pediatric Disease Designation for QRX003 in Peeling Skin Syndrome (Items: 7.01 Regulation FD Disclosure, 8.01 Other Events, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $QNRX

Read the full article at SEC EDGAR

More Regulatory news